InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Deardorf Caren, Directeur Commercial. Director active across 2 companies, notably Magenta Therapeutics, Inc.. Cumulatively, 10 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €36k. Activity tracked since 14 September 2021. The latest transaction was disclosed on 1 September 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Deardorf Caren
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
16,300 股@ US$85.000.015% mcap73.3% 占其流量Common StockSEC:0001628280-26-059901:0
5,925 股@ US$85.000.0056% mcap26.7% 占其流量Common StockSEC:0001628280-26-059901:1
5,925 股Common StockSEC:0001628280-26-044721:0
6,900 股0Common StockSEC:0000950170-25-086269:0
3,400 股0Common StockSEC:0000950170-24-071931:0
6,000 股0Common StockSEC:0001209191-23-038823:0
3,000 股@ US$0.943.6% 占其流量Common StockSEC:0000899243-22-037432:0
3,000 股@ US$0.996.7% 占其流量Common StockSEC:0000899243-22-021185:0
6,238 股@ US$6.7386.6% 占其流量Common StockSEC:0000899243-21-036600:0
20,000 股0Common StockSEC:0000899243-21-036338:0
10 条申报中的 10 条
About Deardorf Caren
Deardorf Caren is Directeur Commercial and appears in 8 filings in total. Across the 8 sampled recent filings, the transactions cover the period from 2021-09-16 to 2026-06-22, with EUR 0 of buys and EUR 35,676 of sells, mainly related to Magenta Therapeutics, Inc. and Crinetics Pharmaceuticals, Inc.
